版本:
中国

BRIEF-Amgen submits Biologics License Application to the FDA for erenumab

May 18 Amgen Inc

* Amgen submits biologics license application to the fda for erenumab

* Amgen inc says bla includes data from pivotal studies in patients with episodic and chronic migraine

* Amgen inc - announced submission of a biologics license application to u.s. Food and drug administration for erenumab to prevent migraine Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐